MED24 Antikörper (Lys834)
Kurzübersicht für MED24 Antikörper (Lys834) (ABIN2963418)
Target
Alle MED24 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 801-850, Lys834
-
Spezifität
- Reacts with human MED24 / TRAP100
-
Kreuzreaktivität
- Maus, Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Cross reacts with mouse and rat protein.
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Synthetic peptide surrounding Lys834 of human TRAP100 / MED24.
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
IF (1:50 - 1:200) IHC (1:50 - 1:200) IHC - P (5 μg/mL) WB (1:500 - 1:1000) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.2, Sodium azide 0.05 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
-
-
- MED24 (Mediator Complex Subunit 24 (MED24))
-
Andere Bezeichnung
- MED24 / TRAP100
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Stem Cell Maintenance, Regulation of Lipid Metabolism by PPARalpha, Positive Regulation of Endopeptidase Activity
Target
-